Masimo Corporation (NASDAQ:MASI), reported Q1 EPS of $0.30, may not compare to the analyst estimate of $0.29. Revenue for the quarter came in at $139.8 million versus the consensus estimate of $144.01 million. Masimo Corporation (NASDAQ:MASI), shares after opening at $26.29 moved to $26.29 on last trade day and at the end of the day closed at $23.95. Company price to sales ratio in past twelve months was calculated as 2.48 and price to cash ratio as 14.22. Masimo Corporation (NASDAQ:MASI), showed a negative weekly performance of 9.69%.
Natural Alternatives International, Inc. (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced the addition of Eugene M. Quast to lead its sales function as Vice President Global Sales. Natural Alternatives International, Inc. (NASDAQ:NAII), shares fell 9.08% in last trading session and ended the day on $5.31. Natural Alternatives International, Inc. (NASDAQ:NAII), return on equity ratio is recorded as 2.70% and its return on assets is 2.40%. Natural Alternatives International, Inc. (NASDAQ:NAII), yearly performance is 19.86%.
On April 30, 2014, Corcept Therapeutics Incorporated (NASDAQ:CORT), announced it will report first quarter financial results and provide a corporate update on May 7, 2014. The Company will also host a conference call that day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). Corcept Therapeutics Incorporated (NASDAQ:CORT), shares moved down 7.24% in last trading session and was closed at $4.10, while trading in range of $ 4.06 – 4.36. Corcept Therapeutics Incorporated (NASDAQ:CORT), year to date (YTD) performance is 27.73%.
Avanir Pharmaceuticals Inc (NASDAQ:AVNR), announced that company management will present an overview of the company at the following conferences in May. Deutsche Bank 39th Annual Health Care Conference. Presentation date: Thursday, May 8, 2014. Presentation time: 2:10 p.m. E.T. Bank of America Merrill Lynch 2014 Health Care Conference. Presentation date: Tuesday, May 13, 2014. Presentation time: 1:00 p.m. P.T. Avanir Pharmaceuticals Inc (NASDAQ:AVNR), weekly performance is 33.24%. On last trading day company shares ended up $4.65. Avanir Pharmaceuticals Inc (NASDAQ:AVNR), distance from 50-day simple moving average (SMA50) is 21.14%. Analysts mean target Price for the company is $7.57.